Skip to main content
. 2011 Dec 1;119(5):1130–1138. doi: 10.1182/blood-2011-09-380436

Figure 5.

Figure 5

Hepatic and renal function of 8 dogs treated with 211At–anti-CD45 mAb-conditioned nonmyeloablative DLA-identical bone marrow transplantation. Eight dogs received 155 to 625 μCi/kg 211At-labeled anti–CD45 mAb on day −3 followed by marrow grafts from a DLA-identical donor on day 0. Dashed lines in graphs indicate the range of values found in normal dogs.